Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable Scaffolds

MAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation.

Subsidie
€ 1.495.288
2024

Projectdetails

Introduction

The extremely popular engineering field of drug-eluting biodegradable scaffolds for regenerative medicine, cancer treatment, and cardiovascular therapies has largely failed to ensure therapy at the right place, at the right time, and with the right dose. Control of actuated drug release is the grand challenge to solve.

Challenges in Current Technologies

Previous attempts struggled because, at this time, no technology is able to cope with the influence of scaffold alterations with degradation.

Project Overview

MAD Control will establish a multifunctional platform for biodegradable cardiovascular scaffolds with the following objectives:

  1. Make model-based predictions of degradation states from real-time imaging.
  2. Reveal which actuation is best for targeted drug release in the actual degradation state.
  3. Uncover how to generate this actuation.

Platform Components

The platform comprises magnetic nanoparticles in hybrid scaffold materials, tailored for a double function:

  • Sensors for magnetic particle imaging.
  • Actuators for drug release with magnetic fluid hyperthermia.

The imaging results are matched with degradation states based on prediction models to be created, and magnetic fluid hyperthermia is induced in a multimodal device to be developed.

Control Mechanism

Control is achieved by coupling material data streams, acquired through automated and comprehensive in-situ measurements of the hybrid materials’ properties, with modelling and control algorithms.

Expected Outcomes

Thus, the multifunctional platform promises a theranostic breakthrough: on-demand release of a precise amount of drugs that can be deliberately chosen. Targeting efficacy is finally measured in vivo, after extensive in-vitro testing.

Transformative Impact

The outcome of this project will be truly transformative, opening new possibilities for research and development of biodegradable implants as well as of magnetic transport and release systems for active agents. Importantly, it is not limited to cardiovascular applications.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.495.288
Totale projectbegroting€ 1.495.288

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERSITAETSKLINIKUM AACHENpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

Advanced 3D in vitro models based on magnetically-driven docking of modular microscaffolds

This project aims to develop 3D modular co-culture systems using magnetic microscaffolds to replicate brain tumor microenvironments for drug screening and cancer therapy testing.

€ 150.000
ERC Proof of...

Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing

ISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies.

€ 150.000
ERC Starting...

Bidirectional remote deep brain control with magnetic anisotropic nanomaterials

BRAINMASTER aims to develop a scalable, wireless neuromodulation system using magnetic nanodiscs for deep brain therapy and imaging, enhancing cognitive training and treatment for neurological disorders.

€ 1.500.000
ERC Starting...

Biodegradable MEMS implants for nerve repair

Develop biodegradable MEMS implants for nerve repair using innovative mechanical stimulation strategies to enhance neural regeneration post-injury.

€ 1.672.968
ERC Starting...

Bioorthogonal Iontronic Chemistry: Spatiotemporal Drug Release with Electronic Precision

Develop a programmable drug delivery system using Biontronic Chemistry for precise spatiotemporal release, enhancing treatment efficacy while minimizing side effects in various therapies.

€ 1.496.795

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration

BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.

€ 4.039.541
EIC Pathfinder

On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs

Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.

€ 2.606.250
EIC Pathfinder

Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterials

BRAINSTORM aims to develop a scalable wireless neuromodulation technology using smart magnetic nanomaterials to selectively control deep brain neurons for therapeutic applications in Fragile X syndrome.

€ 3.083.850
EIC Pathfinder

A synaptic mechanogenetic technology to repair brain connectivity

Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.

€ 3.543.967
EIC Pathfinder

MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation

META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.

€ 2.987.655